معرفی
Dr. Roza Nurieva is a Professor in the Department of Immunology at MD Anderson Cancer Center, serving as Principal Investigator of the Nurieva Laboratory. Her research focuses on elucidating the molecular basis of T cell mediated immune responses and how abnormal immune regulation leads to immunodeficiency, autoimmunity and cancer.
- Institution: MD Anderson Cancer Center
- Department: Immunology
- Position: Professor and Principal Investigator
Dr. Nurieva's research interests center on T follicular helper cells, T cell tolerance mechanisms, and the role of specific proteins like Grail in immune regulation. Her laboratory has made significant contributions to understanding the molecular framework of T cell differentiation and immune regulation. Recent work demonstrated that transplantation of Grail-deficient T cells into a mouse model of lymphoma inhibits tumor growth, suggesting Grail as a potential therapeutic target for improving cancer immune responses. Her research bridges fundamental immunology with translational applications for cancer therapy and autoimmune disease treatment.
Analysis of Dr. Nurieva's publication record reveals consistent focus on immune cell regulation with direct clinical relevance. Her work spans molecular mechanisms of T cell differentiation, immune tolerance, and tumor-immune interactions. Key recurring themes include T follicular helper cell biology, the role of ubiquitin ligases in immune regulation, and molecular pathways of T cell dysfunction in cancer. These research streams converge on developing novel immunotherapeutic approaches that could transform cancer treatment.
- NR4A1 as mediator of T cell dysfunction
- IL-22 in Kras-mutant lung cancer progression
- Molecular regulation of T follicular helper cells
- GRAIL protein in T cell tolerance
Through her leadership at MD Anderson Cancer Center, Dr. Nurieva continues to advance cancer immunology research with the goal of developing more effective immunotherapies that harness the immune system to fight cancer while providing insights applicable to autoimmune disorders.
